Kenneth H. Astrin

2.3k total citations
45 papers, 1.7k citations indexed

About

Kenneth H. Astrin is a scholar working on Molecular Biology, Physiology and Rheumatology. According to data from OpenAlex, Kenneth H. Astrin has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 13 papers in Physiology and 12 papers in Rheumatology. Recurrent topics in Kenneth H. Astrin's work include Porphyrin Metabolism and Disorders (24 papers), Heme Oxygenase-1 and Carbon Monoxide (13 papers) and Folate and B Vitamins Research (12 papers). Kenneth H. Astrin is often cited by papers focused on Porphyrin Metabolism and Disorders (24 papers), Heme Oxygenase-1 and Carbon Monoxide (13 papers) and Folate and B Vitamins Research (12 papers). Kenneth H. Astrin collaborates with scholars based in United States, Spain and Argentina. Kenneth H. Astrin's co-authors include Robert J. Desnick, David F. Bishop, Christine M. Eng, A.S. Henderson, G. Aizencang, Ruth Kornreich, Junaid Shabbeer, Harold S. Bernstein, Weiming Xu and J. Edwin Seegmiller and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Kenneth H. Astrin

45 papers receiving 1.6k citations

Peers

Kenneth H. Astrin
C Borrone Italy
Makiko Yasuda United States
P Guibaud France
W. J. Kleijer Netherlands
C Borrone Italy
Kenneth H. Astrin
Citations per year, relative to Kenneth H. Astrin Kenneth H. Astrin (= 1×) peers C Borrone

Countries citing papers authored by Kenneth H. Astrin

Since Specialization
Citations

This map shows the geographic impact of Kenneth H. Astrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth H. Astrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth H. Astrin more than expected).

Fields of papers citing papers by Kenneth H. Astrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth H. Astrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth H. Astrin. The network helps show where Kenneth H. Astrin may publish in the future.

Co-authorship network of co-authors of Kenneth H. Astrin

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth H. Astrin. A scholar is included among the top collaborators of Kenneth H. Astrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth H. Astrin. Kenneth H. Astrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desnick, Robert J., et al.. (2005). Two Brothers With Mild Congenital Erythropoietic Porphyria Due to a Novel Genotype. Archives of Dermatology. 141(12). 1575–9. 8 indexed citations
2.
Martínez-Bermejo, A, Thomas P. Naidich, Walter E. Kaufmann, et al.. (2004). Acute Intermittent Porphyria. Archives of Neurology. 61(11). 1764–1764. 62 indexed citations
3.
Astrin, Kenneth H., et al.. (2002). Congenital erythropoietic porphyria: advances in pathogenesis and treatment. British Journal of Haematology. 117(4). 779–795. 78 indexed citations
4.
Cunha, Luis F., et al.. (2002). Congenital erythropoietic porphyria: identification and expression of eight novel mutations in the uroporphyrinogen III synthase gene. British Journal of Haematology. 117(4). 980–987. 34 indexed citations
5.
Aizencang, G., et al.. (2001). Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria. Journal of Clinical Investigation. 107(6). 753–762. 71 indexed citations
6.
Cunha, Luis F., Kenneth H. Astrin, David R. Katz, et al.. (2000). Acute intermittent porphyria: novel missense mutations in the human hydroxymethylbilane synthase gene. Genetics in Medicine. 2(5). 290–295. 8 indexed citations
7.
Aizencang, G., David F. Bishop, Douglas Forrest, Kenneth H. Astrin, & Robert J. Desnick. (2000). Uroporphyrinogen III Synthase. Journal of Biological Chemistry. 275(4). 2295–2304. 36 indexed citations
8.
Méndez, Manuel, et al.. (1998). Familial Porphyria Cutanea Tarda: Characterization of Seven Novel Uroporphyrinogen Decarboxylase Mutations and Frequency of Common Hemochromatosis Alleles. The American Journal of Human Genetics. 63(5). 1363–1375. 40 indexed citations
9.
Kauppinen, Raili, Ian A. Glass, G. Aizencang, et al.. (1998). Congenital Erythropoietic Porphyria: Prolonged High-Level Expression and Correction of the Heme Biosynthetic Defect by Retroviral-Mediated Gene Transfer into Porphyric and Erythroid Cells. Molecular Genetics and Metabolism. 65(1). 10–17. 17 indexed citations
10.
Desnick, Robert J., et al.. (1998). Molecular Genetics of Congenital Erythropoietic Porphyria. Seminars in Liver Disease. 18(1). 77–84. 39 indexed citations
11.
Xu, Weiming, Kenneth H. Astrin, & Robert J. Desnick. (1996). Molecular basis of congenital erythropoietic porphyria: Mutations in the human uroporphyrinogen III synthase gene. Human Mutation. 7(3). 187–192. 25 indexed citations
12.
Lee, Grace Y., Kenneth H. Astrin, & Robert J. Desnick. (1995). Acute intermittent porphyria: A single‐base deletion and a nonsense mutation in the human hydroxymethylbilane synthase gene, predicting truncations of the enzyme polypeptide. American Journal of Medical Genetics. 58(2). 155–158. 8 indexed citations
13.
Astrin, Kenneth H. & Robert J. Desnick. (1994). Molecular basis of acute intermittent porphyria: Mutations and polymorphisms in the human hydroxymethylbilane synthase gene. Human Mutation. 4(4). 243–252. 22 indexed citations
15.
Astrin, Kenneth H., Ali Kaya, James G. Wetmur, & Robert J. Desnick. (1991). Rsalpolymorphism in the human §-aminolevulinate dehydratase gene at 9q34. Nucleic Acids Research. 19(15). 4307–4307. 1 indexed citations
16.
Bishop, David F., A.S. Henderson, & Kenneth H. Astrin. (1990). Human δ-aminolevulinate synthase: Assignment of the housekeeping gene to 3p21 and the erythroid-specific gene to the X chromosome. Genomics. 7(2). 207–214. 132 indexed citations
17.
Bernstein, Harold S., David F. Bishop, Kenneth H. Astrin, et al.. (1989). Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene.. Journal of Clinical Investigation. 83(4). 1390–1399. 123 indexed citations
18.
Desnick, Robert J., Harold S. Bernstein, Kenneth H. Astrin, & David F. Bishop. (1987). Fabry Disease:Molecular Diagnosis of Hemizygotes and Heterozygotes. Enzyme. 38(1-4). 54–64. 23 indexed citations
19.
Astrin, Kenneth H., Swan N. Thung, Ronald E. Gordon, et al.. (1987). Cholesteryl ester storage disease: Pathologic changes in an affected fetus. American Journal of Medical Genetics. 26(3). 689–698. 19 indexed citations
20.
Martiniuk, Frank, M. Smith, Amy L. Ellenbogen, et al.. (1983). Assignment of the gene for neutral alpha-glucosidase AB to chromosome 11. Cytogenetic and Genome Research. 35(2). 110–116. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026